Antinociceptive effects of angiotensin-converting enzyme inhibitors and an angiotensin II receptor antagonist in mice
Authors:
- Shinji TakaiShinji Takai
- Keifu SongKSKeifu Song
- Toyoo TanakaTTToyoo Tanaka
- Hideki OkunishiHOHideki Okunishi
- Mizuo MiyazakiMMMizuo Miyazaki
- 1 October 1996
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 59 (21) , PL331-PL336
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Access of peripherally administered DuP 753 to rat brain angiotensin II receptorsBritish Journal of Pharmacology, 1991
- PATHOGENETIC ROLE OF VASCULAR ANGIOTENSIN-CONVERTING ENZYME IN THE SPONTANEOUSLY HYPERTENSIVE RATClinical and Experimental Pharmacology and Physiology, 1991
- Intracerebroventricular administration of angiotensin II attenuates morphine-induced analgesia in miceNeuropharmacology, 1985
- Brain angiotensin: on the way to becoming a well-studied neuropeptide systemBiochemical Pharmacology, 1984
- Vascular Angiotensin-Converting Enzyme Activity in Man and other SpeciesClinical Science, 1984
- Inhibition of in situ metabolism of [3H](met5)-enkephalin and potentiation of (met5)-enkephalin analgesia by captoprilBrain Research, 1980
- Hydrolysis of enkephalin by cultured human endothelial cells and by purified peptidyl dipeptidaseBiochemical Pharmacology, 1978